These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2573078)

  • 1. Dopamine autoreceptor agonists attenuate spontaneous motor activity but not spontaneous fighting in individually-housed mice.
    Wilmot CA; Fico TA; Vanderwende C; Spoerlein MT
    Pharmacol Biochem Behav; 1989 Jun; 33(2):387-91. PubMed ID: 2573078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers.
    Arnt J; Bøgesø KP; Christensen AV; Hyttel J; Larsen JJ; Svendsen O
    Psychopharmacology (Berl); 1983; 81(3):199-207. PubMed ID: 6139838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE; Haubrich DR; Williams M
    Eur J Pharmacol; 1981 Nov; 76(1):15-23. PubMed ID: 7318920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and biochemical studies of dopamine receptor sensitivity in differentially housed mice.
    Wilmot CA; VanderWende C; Spoerlein MT
    Psychopharmacology (Berl); 1986; 89(3):364-9. PubMed ID: 3088665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats.
    Arnt J; Hyttel J
    J Neural Transm; 1984; 60(3-4):205-23. PubMed ID: 6441835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine).
    Jackson D; Carlsson A; Hjorth S; Lindberg P
    J Neural Transm; 1982; 53(4):233-45. PubMed ID: 6286867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of dopamine autoreceptor agonist properties of apomorphine, (+)-3-PPP and (-)-3-PPP by recording of yawning behaviour in rats.
    Ståhle L; Ungerstedt U
    Eur J Pharmacol; 1984 Feb; 98(2):307-10. PubMed ID: 6714314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial learning in male mice with different levels of aggressiveness: effects of housing conditions and nicotine administration.
    Moragrega I; Carrasco MC; Vicens P; Redolat R
    Behav Brain Res; 2003 Dec; 147(1-2):1-8. PubMed ID: 14659564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones.
    Kelly E; Jenner P; Marsden CD
    Neurosci Lett; 1985 May; 56(1):57-62. PubMed ID: 4011049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential behavioural effects of dopamine agonists in developing rats: a study of 3-PPP enantiomers.
    Arnt J
    Eur J Pharmacol; 1983 Jul; 91(2-3):273-8. PubMed ID: 6617748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.
    Hjorth S; Carlsson A; Clark D; Svensson K; Wikström H; Sanchez D; Lindberg P; Hacksell U; Arvidsson LE; Johansson A
    Psychopharmacology (Berl); 1983; 81(2):89-99. PubMed ID: 6415751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the dopaminergic system in the modulation of the acoustic startle response in the rat.
    Svensson L
    Eur J Pharmacol; 1990 Jan; 175(1):107-11. PubMed ID: 1969797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two automated locomotor activity tests for dopamine autoreceptor agonists.
    Schreur PJ; Nichols NF
    Pharmacol Biochem Behav; 1986 Jul; 25(1):255-61. PubMed ID: 2875471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The search for selective dopaminergic autoreceptor agonists.
    Hjorth S; Carlsson A; Clark D; Svensson K; Wikström H; Sanchez D; Lindberg P; Hacksell U; Arvidsson LE; Johansson A; Nilsson JL
    J Neural Transm Suppl; 1983; 18():131-7. PubMed ID: 6576112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M; White FJ
    Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of S (+)-3-phenethyl-PP, a putative dopamine autoreceptors agonist with greater autoreceptor selectivity than 3-PPP enantiomers.
    Arnt J; Bøgesø KP; Hyttel J; Larsen JJ; Svendsen O
    Eur J Pharmacol; 1984 Jun; 102(1):91-9. PubMed ID: 6148247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats.
    Lundström J; Lindgren JE; Ahlenius S; Hillegaart V
    J Pharmacol Exp Ther; 1992 Jul; 262(1):41-7. PubMed ID: 1352554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation.
    Hjorth S; Clark D; Carlsson A
    Eur J Pharmacol; 1988 Aug; 152(3):207-15. PubMed ID: 3146512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.